4.2 Review

A New Insight into the Roles of MiRNAs in Metabolic Syndrome

期刊

BIOMED RESEARCH INTERNATIONAL
卷 2018, 期 -, 页码 -

出版社

HINDAWI LTD
DOI: 10.1155/2018/7372636

关键词

-

资金

  1. Guangdong Provincial Science and Technology Project [2014A020212662]
  2. Science and Technology Planning Project of Southern Medical University [CX2016N018]
  3. Science and Technology Planning Project of Tianhe District, Guangzhou City [201704KW011]
  4. Natural Science Foundation of Guangdong Province [2016A030313559]
  5. South Wisdom Valley Innovative Research Team Program [CXTD-004]
  6. Science and Technique Program of Guangzhou [201604020015]

向作者/读者索取更多资源

Metabolic syndrome (MetS), which includes several clinical components such as abdominal obesity, insulin resistance (IR), dyslipidemia, microalbuminuria, hypertension, proinflammatory state, and oxidative stress (OS), has become a global epidemic health issue contributing to a high risk of type 2 diabetes mellitus (T2DM). In recent years, microRNAs (miRNAs), used as noninvasive biomarkers for diagnosis and therapy, have aroused global interest in complex processes in health and diseases, including MetS and its components. MiRNAs can exist stably in serum, liver, skeletal muscle (SM), heart muscle, adipose tissue (AT), and cells, because of their ability to escape the digestion of RNase. Here we first present an overall review on recent findings of the relationship between miRNAs and several main components of MetS, such as IR, obesity, diabetes, lipid metabolism, hypertension, hyperuricemia, and stress, to illustrate the targeting proteins or relevant pathways that are involved in the progress of MetS and also help us find promising novel diagnostic and therapeutic strategies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Cardiac & Cardiovascular Systems

LncRNAs are Involved in the Process of Atherosclerosis at Diverse Levels

Shiyi Liang, Weicheng Xv, Chijian Li, Yuxiang Huang, Ge Qian, Yuxiang Yan, Hequn Zou, Yongqiang Li

Summary: This review summarizes the recent progress of LncRNAs in the development of atherosclerosis, highlighting their diverse regulatory mechanisms at the transcriptional and post-transcriptional levels, and provides insights into their potential as therapeutic targets or biomarkers for atherosclerosis treatment.

ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2022)

暂无数据